Identification of an Invasive, N-cadherin-expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2001 Nov 7

PMID 11696444

Citations 100

Authors

A Zeitvogel

R Baumann

A Starzinski-Powitz

Affiliations

Soon will be listed here.

Abstract

Studies of molecular, cellular, and pathophysiological parameters in endometriosis are primarily hampered by a lack of in vitro model systems, such as endometriotic cell lines. To overcome this we successfully established cell lines from peritoneal endometriotic biopsies and characterized them at the molecular and cellular level. Two types of cells could be transformed: one exhibiting stromal cell features (cytokeratin/E-cadherin-negative), the other epithelial-like (cytokeratin-positive/E-cadherin-negative, invasive in vitro). Using a Matrigel assay the epithelial-like cell lines proved as invasive as metastatic carcinoma cells, possibly through the influence of N-cadherin implicated as a path-finding cadherin allowing cellular invasion and migration in both normal and pathophysiological processes. Our results support the idea that endometriosis, although not neoplastic, shares features with malignant cells and that metastasis in endometriosis may include mechanisms proposed for micrometastasis in cancer. Thus our cell lines will not only be useful tools for analyzing molecular and cellular events relating to endometriosis, but may also represent a paradigm for invasion and metastasis in general.

Citing Articles

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

de Santiago P, Sato S, Zhang S, Dougher M, Devins K, Bilecz A NPJ Precis Oncol. 2025; 9(1):62.

PMID: 40050409 PMC: 11885553. DOI: 10.1038/s41698-025-00849-1.

Peritoneal Endometriosis Impairs Ovarian Reserve and Increases Atresia in a Rat Model.

Ricci A, Bengochea T, Olivares C, Del Valle S, Simone J, Gemzell-Danielsson K Biomedicines. 2025; 13(2).

PMID: 40002761 PMC: 11853728. DOI: 10.3390/biomedicines13020348.

Modelling Endometriosis Using In Vitro and In Vivo Systems.

Black V, Bafligil C, Greaves E, Zondervan K, Becker C, Hellner K Int J Mol Sci. 2025; 26(2).

PMID: 39859296 PMC: 11766166. DOI: 10.3390/ijms26020580.

Potential Modulatory Role of Phoenixin-14 in Epithelial-Mesenchymal Transition of Endometriotic 12Z Cells.

Kulinska K, Wierzbicka M, Dera-Szymanowska A, Szymanowski K, Andrusiewicz M, Wolun-Cholewa M Biomedicines. 2025; 13(1).

PMID: 39857742 PMC: 11762346. DOI: 10.3390/biomedicines13010158.

Expression of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs () Gene and Its Regulation by miR200b in Ovarian Endometriosis.

Gozdz A, Maksym R, Sciezynska A, Gotte M, Kieda C, Wlodarski P Int J Mol Sci. 2024; 25(21).

PMID: 39519143 PMC: 11547164. DOI: 10.3390/ijms252111594.

References

Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich C . Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med. 2000; 342(8):525-33. DOI: 10.1056/NEJM200002243420801. View

Suginami H . A reappraisal of the coelomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances. Am J Obstet Gynecol. 1991; 165(1):214-8. DOI: 10.1016/0002-9378(91)90254-o. View

Akoum A, Lemay A, Brunet C, Hebert J . Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture. The Groupe d'Investigation en Gynécologie. Am J Obstet Gynecol. 1995; 172(2 Pt 1):594-600. DOI: 10.1016/0002-9378(95)90578-2. View

Zippelius A, Pantel K . RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci. 2000; 906:110-23. DOI: 10.1111/j.1749-6632.2000.tb06600.x. View

Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A . Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol. 1997; 150(2):461-7. PMC: 1858282. View

Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S . Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A. 1995; 92(16):7416-9. PMC: 41350. DOI: 10.1073/pnas.92.16.7416. View

Pantel K, Dickmanns A, Zippelius A, Klein C, Shi J, Schlimok G . Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J Natl Cancer Inst. 1995; 87(15):1162-8. DOI: 10.1093/jnci/87.15.1162. View

Tomita K, van Bokhoven A, van Leenders G, Ruijter E, Jansen C, Bussemakers M . Cadherin switching in human prostate cancer progression. Cancer Res. 2000; 60(13):3650-4. View

Oosterlynck D, Meuleman C, SOBIS H, Vandeputte M, Koninckx P . Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril. 1993; 59(4):778-82. DOI: 10.1016/s0015-0282(16)55859-2. View

10.

Kierstead T, Tevethia M . Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J Virol. 1993; 67(4):1817-29. PMC: 240236. DOI: 10.1128/JVI.67.4.1817-1829.1993. View

11.

Risinger J, Berchuck A, Kohler M, Boyd J . Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet. 1994; 7(1):98-102. DOI: 10.1038/ng0594-98. View

12.

DeCaprio J, Ludlow J, Figge J, Shew J, Huang C, Lee W . SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 1988; 54(2):275-83. DOI: 10.1016/0092-8674(88)90559-4. View

13.

Giroldi L, Bringuier P, Shimazui T, Jansen K, Schalken J . Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int J Cancer. 1999; 82(1):70-6. DOI: 10.1002/(sici)1097-0215(19990702)82:1<70::aid-ijc13>3.0.co;2-#. View

14.

Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V . XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 1996; 86(3):391-9. DOI: 10.1016/s0092-8674(00)80112-9. View

15.

Kim J, Islam S, Kim Y, Prudoff R, Sass K, Wheelock M . N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol. 2000; 151(6):1193-206. PMC: 2190584. DOI: 10.1083/jcb.151.6.1193. View

16.

Dawood M, Wilson Jr L . Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. Am J Obstet Gynecol. 1984; 148(4):391-5. DOI: 10.1016/0002-9378(84)90713-0. View

17.

Perl A, Wilgenbus P, Dahl U, Semb H, Christofori G . A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998; 392(6672):190-3. DOI: 10.1038/32433. View

18.

Weil S, Wang S, Perez M, Lyttle C . Chemotaxis of macrophages by a peritoneal fluid protein in women with endometriosis. Fertil Steril. 1997; 67(5):865-9. DOI: 10.1016/s0015-0282(97)81398-2. View

19.

Giudice L, Dsupin B, Gargosky S, Rosenfeld R, Irwin J . The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis. J Clin Endocrinol Metab. 1994; 79(5):1284-93. DOI: 10.1210/jcem.79.5.7525631. View

20.

Umbas R, Schalken J, Aalders T, Carter B, Karthaus H, Schaafsma H . Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992; 52(18):5104-9. View